Vaccination during bispecific antibody treatment for myeloma. [PDF]
Banerjee R, Raje NS.
europepmc +1 more source
Protocol for the economic evaluation of the Care for Adolescents who Received Information 'Bout Outcomes, 2nd iteration (CARIBOU-2) non-randomised, cluster-controlled trial of an integrated care pathway for depression in adolescents. [PDF]
de Oliveira C +6 more
europepmc +1 more source
New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma. [PDF]
Greenbaum U +44 more
europepmc +1 more source
Energy Infrastructure Clears the Way for Coyotes in Alberta's Oil Sands. [PDF]
Clarke JF +7 more
europepmc +1 more source
CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting. [PDF]
Hunter BD +18 more
europepmc +1 more source
Youth partner engagement in the development of an integrated care pathway for the treatment of adolescents with depression. [PDF]
Prebeg M +7 more
europepmc +1 more source
Author Correction: Quantifying forest disturbance regimes within caribou (Rangifer tarandus) range in British Columbia. [PDF]
Maltman JC +4 more
europepmc +1 more source
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience. [PDF]
Afrough A +45 more
europepmc +1 more source
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma. [PDF]
Jagannath S +32 more
europepmc +1 more source

